
Craig James Price
Examiner (ID: 4133, Phone: (571)272-2712 , Office: P/3753 )
| Most Active Art Unit | 3753 |
| Art Unit(s) | 3753 |
| Total Applications | 1330 |
| Issued Applications | 846 |
| Pending Applications | 107 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10116867
[patent_doc_number] => 09151743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/127834
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 16728
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127834 | Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors | Oct 4, 2009 | Issued |
Array
(
[id] => 6177249
[patent_doc_number] => 20110177970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'METHODS FOR PREDICTING OR MONITORING WHETHER A PATIENT AFFECTED BY A CANCER IS RESPONSIVE TO A TREATMENT WITH A MOLECULE OF THE TAXOID FAMILY'
[patent_app_type] => utility
[patent_app_number] => 13/121975
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27604
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177970.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121975 | METHODS FOR PREDICTING OR MONITORING WHETHER A PATIENT AFFECTED BY A CANCER IS RESPONSIVE TO A TREATMENT WITH A MOLECULE OF THE TAXOID FAMILY | Oct 1, 2009 | Abandoned |
Array
(
[id] => 6177275
[patent_doc_number] => 20110177973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'COMBINATORIAL SYNTHESIS AND USE OF LIBRARIES OF SHORT EXPRESSED NUCLEIC ACID SEQUENCES FOR THE ANALYSIS OF CELLULAR EVENTS'
[patent_app_type] => utility
[patent_app_number] => 13/120616
[patent_app_country] => US
[patent_app_date] => 2009-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17373
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177973.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120616
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120616 | COMBINATORIAL SYNTHESIS AND USE OF LIBRARIES OF SHORT EXPRESSED NUCLEIC ACID SEQUENCES FOR THE ANALYSIS OF CELLULAR EVENTS | Sep 23, 2009 | Abandoned |
Array
(
[id] => 6428520
[patent_doc_number] => 20100168389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'PROCESS FOR PRODUCING EXTRACT FOR CELL-FREE PROTEIN SYNTHESIS AND CELL EXTRACT PRODUCED THEREBY'
[patent_app_type] => utility
[patent_app_number] => 12/565638
[patent_app_country] => US
[patent_app_date] => 2009-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6760
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168389.pdf
[firstpage_image] =>[orig_patent_app_number] => 12565638
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/565638 | PROCESS FOR PRODUCING EXTRACT FOR CELL-FREE PROTEIN SYNTHESIS AND CELL EXTRACT PRODUCED THEREBY | Sep 22, 2009 | Abandoned |
Array
(
[id] => 6016877
[patent_doc_number] => 20110224243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'FZD2 Molulators in the Treatment of Alopecia'
[patent_app_type] => utility
[patent_app_number] => 13/120103
[patent_app_country] => US
[patent_app_date] => 2009-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5445
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224243.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120103
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120103 | FZD2 Molulators in the Treatment of Alopecia | Sep 20, 2009 | Abandoned |
Array
(
[id] => 6165604
[patent_doc_number] => 20110195420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'ESTROGEN AND ANTI-ESTROGEN MARKER GENES'
[patent_app_type] => utility
[patent_app_number] => 13/122987
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22157
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195420.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122987
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122987 | ESTROGEN AND ANTI-ESTROGEN MARKER GENES | Sep 17, 2009 | Abandoned |
Array
(
[id] => 7573577
[patent_doc_number] => 20110269233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY'
[patent_app_type] => utility
[patent_app_number] => 13/063912
[patent_app_country] => US
[patent_app_date] => 2009-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24385
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269233.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063912
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063912 | COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY | Sep 14, 2009 | Abandoned |
Array
(
[id] => 7501378
[patent_doc_number] => 20110263447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'METHOD FOR THE PROGNOSIS AND DIAGNOSIS OF TYPE II DIABETES IN CRITICAL PERSONS'
[patent_app_type] => utility
[patent_app_number] => 13/063582
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11316
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263447.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063582
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063582 | METHOD FOR THE PROGNOSIS AND DIAGNOSIS OF TYPE II DIABETES IN CRITICAL PERSONS | Sep 13, 2009 | Abandoned |
Array
(
[id] => 7696710
[patent_doc_number] => 20110229880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'GENE SILENCING'
[patent_app_type] => utility
[patent_app_number] => 13/063408
[patent_app_country] => US
[patent_app_date] => 2009-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18872
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229880.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063408
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063408 | GENE SILENCING | Sep 9, 2009 | Abandoned |
Array
(
[id] => 7807185
[patent_doc_number] => 20120058139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'NOVEL MULTIMODULAR ASSEMBLY USEFUL FOR INTRACELLULAR DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/062339
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11724
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058139.pdf
[firstpage_image] =>[orig_patent_app_number] => 13062339
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/062339 | Multimodular assembly useful for intracellular delivery | Sep 1, 2009 | Issued |
Array
(
[id] => 6102091
[patent_doc_number] => 20110165583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'VECTOR FOR IDENTIFICATION, SELECTION AND EXPRESSION OF RECOMBINANTS'
[patent_app_type] => utility
[patent_app_number] => 13/061640
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7537
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165583.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061640 | VECTOR FOR IDENTIFICATION, SELECTION AND EXPRESSION OF RECOMBINANTS | Sep 1, 2009 | Abandoned |
Array
(
[id] => 6015725
[patent_doc_number] => 20110223635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'Method and Composition for Controlling Gene Expression'
[patent_app_type] => utility
[patent_app_number] => 13/057695
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17343
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223635.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057695
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057695 | Method and Composition for Controlling Gene Expression | Aug 10, 2009 | Abandoned |
Array
(
[id] => 7587240
[patent_doc_number] => 20110281750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'Identifying High Risk Clinically Isolated Syndrome Patients'
[patent_app_type] => utility
[patent_app_number] => 13/055684
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 37827
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281750.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055684
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055684 | Identifying High Risk Clinically Isolated Syndrome Patients | Jul 23, 2009 | Abandoned |
Array
(
[id] => 7662760
[patent_doc_number] => 20110312029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'NOVEL REGULATORY ELEMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/055017
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15445
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312029.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055017 | Regulatory elements | Jul 21, 2009 | Issued |
Array
(
[id] => 7778145
[patent_doc_number] => 20120040849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'GENE EXPRESSION PROFILE AS AN ENDOMETRIAL RECEPTIVITY MARKER'
[patent_app_type] => utility
[patent_app_number] => 13/057135
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 8985
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040849.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057135
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057135 | Gene expression profile as an endometrial receptivity marker | Jul 21, 2009 | Issued |
Array
(
[id] => 8139487
[patent_doc_number] => 20120094294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'BMS1 PROTEIN EXPRESSION SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/737482
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9485
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094294.pdf
[firstpage_image] =>[orig_patent_app_number] => 12737482
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/737482 | BMS1 PROTEIN EXPRESSION SYSTEM | Jul 16, 2009 | Abandoned |
Array
(
[id] => 6111328
[patent_doc_number] => 20110189730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'VIRAL NUCLEOCAPSID PROTEIN AS A MULTIFUNCTIONAL TRANSLATION INITIATION FACTOR AND INCREASED PROTEIN AND POLYPEPTIDE PRODUCTION USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/002677
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22366
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189730.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002677
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002677 | VIRAL NUCLEOCAPSID PROTEIN AS A MULTIFUNCTIONAL TRANSLATION INITIATION FACTOR AND INCREASED PROTEIN AND POLYPEPTIDE PRODUCTION USING SAME | Jul 16, 2009 | Abandoned |
Array
(
[id] => 5959477
[patent_doc_number] => 20110183864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'METHOD FOR LUNG CANCER EARLY DETECTION AND PROGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/054143
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13075
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183864.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054143
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054143 | METHOD FOR LUNG CANCER EARLY DETECTION AND PROGNOSIS | Jul 14, 2009 | Abandoned |
Array
(
[id] => 6112775
[patent_doc_number] => 20110190156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'MOLECULAR SIGNATURES FOR DIAGNOSING SCLERODERMA'
[patent_app_type] => utility
[patent_app_number] => 13/054244
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 45365
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190156.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054244
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054244 | MOLECULAR SIGNATURES FOR DIAGNOSING SCLERODERMA | Jul 14, 2009 | Abandoned |
Array
(
[id] => 7586789
[patent_doc_number] => 20110281299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto'
[patent_app_type] => utility
[patent_app_number] => 13/054187
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6370
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281299.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054187
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054187 | Recombinant pokeweed antiviral proteins, compositions and methods related thereto | Jul 14, 2009 | Issued |